BACKGROUND: Although black cisgender women in Chicago continue to disproportionally account for new HIV diagnoses, few are on pre-exposure prophylaxis (PrEP). We used concurrent mixed-methods to understand women's PrEP knowledge, attitudes, experience, and preferences in Chicago. SETTING AND METHODS: We surveyed 370 HIV(-) cisgender women visiting a sexually transmitted infection clinic (n = 120) or emergency department (n = 250). Two focus groups were conducted with PrEP-naive women, and interviews were conducted with 7 PrEP-experienced women. Quantitative data were analyzed using descriptive statistics and multivariable logistic regression, and qualitative data using thematic analysis. RESULTS: Majority of women identified as black (83.0%) and had a regular source of health care (70.0%). In the past 6 months, 84.1% had vaginal or anal sex, most with inconsistent condom use (94.2%). Only 30.3% had heard of PrEP, but once explained, one-quarter considered starting PrEP, with protecting health (76.4%) and reducing HIV worry (58.1%) the most common reasons. Factors associated with considering PrEP included being Latina [adjusted odds ratio (aOR): 3.30, 95% confidence interval (CI): (1.21 to 8.99)], recent sexually transmitted infection [aOR: 2.39, 95% CI: (1.25 to 4.59)], and higher belief in PrEP effectiveness [aOR: 1.85, 95% CI: (1.22 to 2.82)]. Most (81.1%) had concerns about taking PrEP with side effects a common concern. Qualitative themes aligned with survey results, revealing a disconnection from current PrEP marketing, need for community-level PrEP education/outreach, and importance of provider trust. LESSONS LEARNED: Despite significant PrEP implementation work in Chicago, less than one-third of women in our study had heard of PrEP. Once informed, PrEP attitudes and interest were positive. Translating these results into interventions reflecting women's preferences and barriers is critical to increase PrEP uptake by cisgender women in Chicago and elsewhere.
BACKGROUND: Although black cisgender women in Chicago continue to disproportionally account for new HIV diagnoses, few are on pre-exposure prophylaxis (PrEP). We used concurrent mixed-methods to understand women's PrEP knowledge, attitudes, experience, and preferences in Chicago. SETTING AND METHODS: We surveyed 370 HIV(-) cisgender women visiting a sexually transmitted infection clinic (n = 120) or emergency department (n = 250). Two focus groups were conducted with PrEP-naive women, and interviews were conducted with 7 PrEP-experienced women. Quantitative data were analyzed using descriptive statistics and multivariable logistic regression, and qualitative data using thematic analysis. RESULTS: Majority of women identified as black (83.0%) and had a regular source of health care (70.0%). In the past 6 months, 84.1% had vaginal or anal sex, most with inconsistent condom use (94.2%). Only 30.3% had heard of PrEP, but once explained, one-quarter considered starting PrEP, with protecting health (76.4%) and reducing HIV worry (58.1%) the most common reasons. Factors associated with considering PrEP included being Latina [adjusted odds ratio (aOR): 3.30, 95% confidence interval (CI): (1.21 to 8.99)], recent sexually transmitted infection [aOR: 2.39, 95% CI: (1.25 to 4.59)], and higher belief in PrEP effectiveness [aOR: 1.85, 95% CI: (1.22 to 2.82)]. Most (81.1%) had concerns about taking PrEP with side effects a common concern. Qualitative themes aligned with survey results, revealing a disconnection from current PrEP marketing, need for community-level PrEP education/outreach, and importance of provider trust. LESSONS LEARNED: Despite significant PrEP implementation work in Chicago, less than one-third of women in our study had heard of PrEP. Once informed, PrEP attitudes and interest were positive. Translating these results into interventions reflecting women's preferences and barriers is critical to increase PrEP uptake by cisgender women in Chicago and elsewhere.
Authors: Sarah K Calabrese; Tiara C Willie; Rachel W Galvao; Mehrit Tekeste; John F Dovidio; Cara B Safon; Oni Blackstock; Tamara Taggart; Clair Kaplan; Abigail Caldwell; Trace S Kershaw Journal: J Acquir Immune Defic Syndr Date: 2019-08-01 Impact factor: 3.731
Authors: Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan Journal: Ann Epidemiol Date: 2018-06-15 Impact factor: 3.797
Authors: Gabriela Poles; Michelle Li; Hellen Siril; Aisa Mhalu; Claudia Hawkins; Sylvia Kaaya; Eric Aris; Guerino Chalamilla; Lisa R Hirschhorn Journal: J Int Assoc Provid AIDS Care Date: 2012-12-26
Authors: Albert Y Liu; Eric Vittinghoff; Patricia von Felten; K Rivet Amico; Peter L Anderson; Richard Lester; Erin Andrew; Ixchell Estes; Pedro Serrano; Jennifer Brothers; Susan Buchbinder; Sybil Hosek; Jonathan D Fuchs Journal: Clin Infect Dis Date: 2019-05-30 Impact factor: 9.079
Authors: Allison L Kimmel; Lisa J Messersmith; Angela R Bazzi; Meg M Sullivan; Jacqueline Boudreau; Mari-Lynn Drainoni Journal: J HIV AIDS Soc Serv Date: 2021-02-22
Authors: Rachel K Scott; Shawnika J Hull; Jim C Huang; Megan Coleman; Peggy Ye; Pam Lotke; Jason Beverley; Patricia Moriarty; Dhikshitha Balaji; Allison Ward; Jennifer Holiday; Ashley R Brant; Martha Cameron; Rick Elion; Adam Visconti Journal: Arch Sex Behav Date: 2022-05-27
Authors: Amy K Johnson; Maria Pyra; Samantha Devlin; A Ziggy Uvin; Shemeka Irby; Cori Blum; Eric Stewart; Lisa Masinter; Sadia Haider; Lisa R Hirschhorn; Jessica P Ridgway Journal: J Acquir Immune Defic Syndr Date: 2022-07-01 Impact factor: 3.771
Authors: Jessica P Ridgway; Eleanor E Friedman; Alvie Bender; Jessica Schmitt; Michael Cronin; Rayna N Brown; Amy K Johnson; Lisa R Hirschhorn Journal: AIDS Patient Care STDS Date: 2021-01 Impact factor: 5.078
Authors: Gabriella Y Jackson; Caroline K Darlington; Hong Van Tieu; Bridgette M Brawner; Dalmacio D Flores; Jacqueline A Bannon; Annet Davis; Victoria Frye; Deepti Chittamuru; Paige Gugerty; Beryl A Koblin; Anne M Teitelman Journal: Cult Health Sex Date: 2021-02-04
Authors: Anne M Teitelman; Hong-Van Tieu; Dalmacio Flores; Jacqueline Bannon; Bridgette M Brawner; Annet Davis; Paige Gugerty; Beryl Koblin Journal: AIDS Care Date: 2021-03-09